Bedaquiline Adherence Measured by Electronic Dose Monitoring Predicts Clinical Outcomes in the Treatment of Patients With Multidrug-Resistant Tuberculosis and HIV/AIDS

Novel regimens have revolutionized multidrug-resistant tuberculosis (MDR-TB) treatment; however, medication adherence remains challenging and poorly characterized. We hypothesized that bedaquiline adherence, measured using electronic dose monitoring, would predict MDR-TB treatment outcomes. This is...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of acquired immune deficiency syndromes (1999) Jg. 90; H. 3; S. 325
Hauptverfasser:	O'Donnell, Max R, Padayatchi, Nesri, Wolf, Allison, Zelnick, Jennifer, Daftary, Amrita, Orrell, Catherine, Nimmo, Camus, Baldwin, Matthew, Boodhram, Resha, Maharaj, Bhavna, Amico, K Rivet, Naidoo, Kogieleum, Friedland, Gerald
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	United States 01.07.2022
Schlagworte:	Acquired Immunodeficiency Syndrome - drug therapy Adult Antitubercular Agents - therapeutic use Diarylquinolines Electronics HIV Infections - complications Humans Prospective Studies South Africa Treatment Outcome Tuberculosis, Multidrug-Resistant - complications South Africa
ISSN:	1944-7884, 1944-7884
Online-Zugang:	Weitere Angaben
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!